PLX Long-Term Debt
Protalix Biotherapeutics Inc · Long-Term Debt
PLX Long-Term Debt
Latest reported$7.54Mperiod ending
PLX Quarterly Long-Term Debt ($0.00 → $7.54M)
Quarterly long-term debt
High-resolution chart · PNG
PLX long-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Debt (USD) |
|---|---|
| 7,541,000 | |
| 7,048,000 | |
| 6,937,000 | |
| 6,780,000 | |
| 3,877,000 | |
| 3,811,000 | |
| 4,026,000 | |
| 4,176,000 | |
| 4,282,000 | |
| 4,499,000 | |
| 4,621,000 | |
| 4,502,000 | |
| 24,709,000 | |
| 32,419,000 | |
| 32,356,000 | |
| 32,141,999 | |
| 31,926,000 | |
| 32,155,000 | |
| 32,263,000 | |
| 32,257,000 | |
| 4,507,000 | |
| 4,319,000 | |
| 4,467,000 | |
| 58,063,000 | |
| 57,148,000 | |
| 56,258,000 | |
| 55,485,000 | |
| 54,695,000 | |
| 53,967,000 | |
| 53,168,000 | |
| 47,966,000 | |
| 47,320,000 | |
| 46,742,000 | |
| 46,108,000 | |
| 46,267,000 | |
| 57,926,000 | |
| 57,881,000 | |
| 117,505,000 | |
| 23,644,000 | |
| 72,430,000 | |
| 72,318,000 | |
| 72,207,000 | |
| 72,097,000 | |
| 67,774,000 | |
| 67,670,000 | |
| 67,566,000 | |
| 67,351,000 | |
| 67,359,000 | |
| 67,255,000 | |
| 67,151,000 | |
| 67,048,000 | |
| 66,944,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 4,680,000 | |
| 0 | |
| 0 | |
| 0 | |
| 4,452,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |